. Gelbart and colleagues identified Mad by a suppressor/enhancer screen for genes interacting with DPP during fly embryogenesis.
Figure 1. Amino Acid Sequences of Xmad1 and Xmad2
Alignment of the predicted protein sequences of Xenopus Xmad1 and Xmad2. Identical residues are indicated by a stippled background. Two marks enclose an alternatively spliced exon in Xmad2.
Xmads Function in Discrete Pathways
Xenopus laevis animal pole explants normally become et al., 1988; Thomsen et al., 1990; Green et al., 1990;  (B) Morphological assay for Xmad function. Control (Con) animal Dale et al., 1993; Thomsen and Melton, 1993 synthetic mRNAs encoding a Xmad protein were inXmad1-expressing caps have vesicles (V), mesenchyme, and mesojected into the animal poles of fertilized eggs, and animal thelium (Me). Elongated Xmad2-injected caps contain muscle (M) caps were removed, cultured, and then assayed for and notochord (N). mesoderm induction (Figure 2A ). When Xmad1 is expressed in an animal pole explant, ventral mesoderm forms, as evidenced by fluid-filled vesicles ( Figure 2B) shown). Molecular analysis demonstrates that mesoderm induced by Xmad2 does not express the ventral containing mesenchyme and mesothelium ( Figure 2C ). Animal caps injected with Xmad1 do not express the marker globin, but does express the dorsal markers goosecoid and muscle actin (Figure 3 ). Therefore, dorsal mesodermal markers goosecoid or muscle actin or the neural marker, neural cell adhesion molecule Xmad2, like activin, Vg1, TGF␤, and nodal, induces dorsal mesoderm. Thus, Xmad1 and Xmad2 produce two (N-CAM), but do express globin, a definitive marker of ventral mesoderm (Figure 3) . Unexpectedly, formation distinct and easily distinguished biological responses: Xmad1 produces ventral mesoderm and Xmad2 proof ventral mesoderm by Xmad1 occurs in the absence of expression of the early markers for mesoderm, such duces dorsal mesoderm.
To demonstrate further that the distinct responses as brachyury (Figure 3) . In all, these data show that Xmad1 induces the same type of mesoderm (ventral) seen with Xmad1 and Xmad2 are qualitative differences and not concentration-dependent differences, we asthat is observed when animal caps are induced by BMP2 or BMP4 (Koster et al., 1991; Dale et al., 1992; Jones et sayed the two Xmads at doses ranging from 15.6 pg to 2 ng (Figure 4 ). Xmad2 induces mesoderm over a broad al., 1992; Hemmati-Brivanlou and Thomsen, 1995) .
In contrast, when Xmad2 is expressed in the animal range of doses from 125 pg to 2 ng ( Figure 4A ) and can induce mesoderm formation at a dose of 60 pg (data pole, the tissue elongates in a manner characteristic of dorsal mesoderm ( Figure 2B ), and histological analyses not shown). Higher concentrations of Xmad2 induce expression of goosecoid, a marker for the most dorsal demonstrate the presence of muscle and notochord ( Figure 2C ). This is confirmed by immunohistochemistry mesoderm. At lower Xmad2 concentrations, goosecoid is not expressed, but the ventral-lateral marker Xwnt-8 with a muscle-specific monoclonal antibody, 12/101, and a notochord-specific antibody, Tor70.1 (data not is expressed. Significantly, no concentration of Xmad2
When mRNAs encoding Xmad1 and Xmad2 are coinjected, both dorsal and ventral mesoderm are induced. Figure 4C shows that coinjection leads to induction of the dorsal marker muscle actin and the ventral marker globin.
Taken together, these data demonstrate that Xmad1 induces ventral mesoderm, mimicking the effects of BMP2 and BMP4, whereas Xmad2 induces dorsal mesoderm, mimicking the effects of dorsal-inducing ligands such as activin and Vg1. Thus, the Xmad proteins have qualitatively distinct activities in embryonic mesoderm induction.
Xmads Are Uniformly Expressed during Embryonic Development
Since individual Xmads induce either ventral or dorsal mesoderm, but not both, their localization or differential activation could explain how embryonic mesoderm is initially established and patterned. We determined the spatial distribution of the Xmad transcripts in various regions of developing embryos by reverse transcription-PCR (RT-PCR). Xmad RNAs are maternally expressed, since the cDNAs were recovered from an oocyte library. The RNAs are present in the blastula stage, and both family ligands affects transcription of Xmad genes, we Brachyury is a marker of general mesoderm (Smith et al., 1991a) .
added BMP4 or activin protein to ectodermal explants
Goosecoid is a marker of dorsal mesoderm (Cho et al., 1991) . and analyzed Xmad mRNA levels at 40 min intervals Xwnt-8 is a marker of ventral and lateral mesoderm (Christian et al., 1991; Smith and Harland, 1991) . Muscle actin is a marker for the until mesoderm was induced. As expected, both BMP4 dorsal and lateral tissue, muscle (Mohun et al., 1984) . Globin is a and activin induce mesoderm, assayed here by expresmarker of blood and is a definitive ventral marker (Hemmati-Brivansion of brachyury RNA at 160 min ( Figure 5 ). The level lou et al., 1990) . N-CAM is a marker of neural tissue (Kintner and of Xmad1 and Xmad2 mRNA is unaffected at all four . timepoints ( Figure 5 ), suggesting that transcription of Xmad1 and Xmad2 is not significantly altered by mesoleads to the expression of the ventral marker globin.
derm induction. In all, these data indicate the presence These results reproduce the concentration effects obof a nearly uniform and constant amount of Xmad1 and tained with varying doses of activin and Vg1, TGF␤ moleXmad2 mRNAs in early development. cules that induce dorsal mesoderm (Green et al., 1990 (Green et al., , 1992 Wilson and Melton, 1994; Kessler and Melton Xmads Function Downstream of the Receptor 1995).
We tested the position of the Xmads within the TGF␤ The results obtained with Xmad1 contrast with those signaling cascade using truncated receptors that funcproduced by Xmad2 ( Figure 4B ). At no dose does Xmad1 tion as dominant-negative receptors. One expects siginduce any of the dorsal markers goosecoid, actin, or nals that function upstream of the receptor to be blocked N-CAM, but Xmad1 does induce expression of globin, by a truncated receptor, whereas signals acting downmimicking BMP2 and BMP4. In addition, Xmad1 appears stream of the receptor might be unaffected (Herskowitz, to be much less potent than Xmad2, requiring nanogram 1987; Amaya et al., 1991;  Hemmati-Brivanlou and Melquantities of mRNA to produce mesoderm. This too ton, 1992; Graff et al., 1994; Suzuki et al., 1994 ; Umbmimics the effects seen with the ligands, as BMPs are hauer et al., 1995). Xmad1 appears to be located in the less potent than either activin or Vg1 (Thomsen et al., BMP-specific pathway, and the truncated BMP receptor 1990; Thomsen and Melton, 1993 ; Hemmati-Brivanlou and Thomsen, 1995) .
does not affect the Xmad1-dependent morphologic or histologic induction of ventral mesoderm, as evidenced Another way to determine if Xmad1 is downstream of receptors is to test whether Xmad1 can reverse phenoby the fact that vesicles, mesenchyme, and mesothelium form unabated when Xmad1 is coexpressed with the typic effects of the truncated dominant-negative receptors. The truncated BMP receptor, which blocks BMP dominant-negative BMP receptor ( Figure 6A ). In contrast with this lack of effect on morphology and histolsignaling, leads to a weak induction of neural tissue, as demonstrated by the induction of N-CAM ( Figure 6C ) ogy, the truncated BMP receptor does block the Xmad1-dependent induction of globin ( Figure 6B ). The formation (Sasai et al., 1995; Hawley et al., 1995) . Similarly, the truncated activin receptor, which blocks all tested TGF␤ of vesicles, mesenchyme, and mesothelium is an early and potentially direct effect of expression of Xmad1 (and signals including BMPs, induces neural tissue and does so more potently than the truncated BMP receptor BMP signaling), whereas expression of globin is a late effect that presumably requires many steps, and the ( Figure 6C ) (Hemmati-Brivanlou and Melton, 1992; Schulte-Merker et al., 1994; Kessler and Melton, 1995 ; truncated BMP receptor may alter a later step without blocking Xmad1 function per se. The blockade of globin Hemmati-Brivanlou and Thomsen, 1995) . Xmad1 completely reverses the induction of N-CAM by either of expression might also be explained by the truncated BMP receptor inhibiting endogenous BMP signaling the truncated receptors, implying that Xmad1 functions downstream of the receptor. This reversal of N-CAM present in animal caps (Graff et al., 1994; Suzuki et al., 1994; Hawley et al., 1995; Sasai et al., 1995; Schmidt expression is not seen when BMP4 is coexpressed with the truncated BMP receptor (Sasai et al., 1995 (Sasai et al., ). et al., 1995 Wilson and Hemmati-Brivanlou, 1995) . If ectopic expression of Xmad1 requires endogenous BMP Xmad2 appears to function in the activin/Vg1-like dorsal pathway, so we determined whether the dominantactivity to induce globin, then the truncated BMP receptor may eliminate globin expression by blocking endogenegative activin receptor would block Xmad2 function. The truncated activin receptor blocks activin and Vg1 nous BMP signaling. In support of this interpretation, coexpression of BMP4 and Xmad1 mRNA in quantities function and formation of all dorsal mesoderm (Hemmati-Brivanlou and Melton, 1992; Schulte-Merker et al., that on their own have no effect leads to induction of globin (data not shown).
1994; Kessler and Melton, 1995). Microinjection of the
Xmads Are Present in the Cytoplasm and the Nucleus
To determine the subcellular location of Xmad proteins, we microinjected oocytes with synthetic mRNA encoding either Xmad1 or Xmad2 and incubated the oocytes with 35 S-containing amino acids. Newly synthesized proteins were assayed from oocyte culture media (containing secreted proteins), manually isolated nuclei, and biochemically fractionated membranes and cytoplasm. Gel fractionation of newly synthesized proteins ( Figure  7) shows that the Xmad proteins are present in both the nucleus and cytoplasm, but they are not in the membrane fraction or secreted into the media. Close inspection of the nuclear and cytoplasmic lanes reveals that the nuclear Xmad protein appears slightly larger. This reproducible effect suggests that the nuclear protein may be posttranslationally modified. To eliminate the possibility that the nuclear or cytosolic localization of Xmads is due to overexpression, we expressed Xmads at lower concentrations and determined their subcelluar location by Western blotting. When the Xmads were expressed at the detection limit of the antibody (20-to 100-fold less mRNA than that used in Figure 7 ), the protein is still found in both the cytosol and nucleus.
Discussion
The results presented here show that the Xmads are components of the vertebrate TGF␤ signaling pathway. Expression of individual Xmad proteins mimics the effects of specific subsets of TGF␤ signals in mesoderm precedent of other signal transduction cascades, it is possible that a ligand-dependent change leads to translocation of Xmad proteins from one compartment to the other (Verma et al., 1995) . As the Xmads are part of a truncated activin receptor leads to expression of N-CAM, which demonstrates that the dominant-negasignaling cascade initiated by a receptor serine/threonine kinase, it is feasible that the size difference between tive activin receptor is active ( Figure 6D ) (Hemmati-Brivanlou and Melton, 1992) . Coexpression of the domithe nuclear and cytosolic versions is accounted for by phosphorylation. Indeed, preliminary experiments sugnant-negative activin receptor with Xmad2 does not block the morphogenetic elongation induced by Xmad2 gest that the Xmads are phosphoproteins (J. M. G., P. J. Blackshear, D. J. Stumpo, and D. A. M., unpublished (data not shown). Furthermore, the dominant-negative activin receptor has no effect on mesoderm formed by data). Xmad1 appears to transduce the BMP set of signals Xmad2, as demonstrated by the lack of effect on the molecular markers brachyury and muscle actin (Figure for ventral mesoderm induction, whereas Xmad2 transduces the activin/Vg1/Nodal/TGF␤ signals to form dor-6D). These results support the contention that Xmads function downstream of the receptors.
sal mesoderm. Thus, it appears that the Xmads act as an integrating point in the signaling pathway. It remains Xmad1 and Xmad2 mRNAs. Thus, a BMP signal is likely to activate Xmad1 on the ventral side of the embryo, to be determined precisely how the other subsets of the TGF␤ superfamily will be divided among the various whereas a dorsal-inducing signal (possibly Vg1 or activin) activates Xmad2 on the future dorsal side. Xmads. There are at least two other maternal Xmads (Xmad3 and Xmad4) in Xenopus, and these have yet to An unexpected finding is that formation of ventral mesoderm by Xmad1 occurs in the absence of brachybe functionally associated with TGF␤ signals. Relatedly, it remains to be determined whether there are more ury expression (Figure 3 ). Xmad1 may directly activate differentiation for ventral mesoderm and not require exXmad-related genes in flies and worms and how these might correspond to TGF␤ superfamily ligands in those pression of brachyury. Indeed, while brachyury is considered to be a general marker for embryonic mesoderm, organisms. The number of mammalian Xmad proteins is yet to be determined, but their clinical significance there is no experiment that demonstrates that all mesoderm formation requires brachyury expression. In what is highlighted by a recent report on human pancreatic cancers. Hahn et al. (1996) have identified a candidate may be a parallel example, the gene neuroD can apparently bypass early inhibitory influences that prevent neutumor suppressor gene, DPC4, that is deleted in pancreatic cancers and have shown its sequence homology rogenesis in Xenopus and directly convert animal cap cells to neurons (Lee et al., 1995) . to Mad and CEM genes. Sequence comparison suggests that DPC4 is the human homolog of the molecule All the injections reported in this paper were done with mRNAs encoding wild-type Xmad proteins, not muthat we term Xmad4.
With respect to understanding mesoderm induction tant or constitutively active forms. Why does injection of wild-type Xmad mRNA, which is already present in in Xenopus, our results show no differences in the distribution of maternal or zygotic Xmad mRNAs, and prethe embryo, lead to formation of mesoderm? Evidently, injection of Xmad mRNA leads to production of active sumably their corresponding proteins are uniformly distributed along the future body axes. In other words, all
Xmad protein, and this could occur by a number of mechanisms. Animal cap cells have endogenous BMP cells in the marginal zone of early embryos are in principle capable of responding to either a dorsal mesodermand activin mRNAs and are presumably exposed to a low level of the BMP and activin signaling pathways, or ventral mesoderm-inducing signal by virtue of having individual Xmad may be determined by the number of phosphorylated residues, which in turn reflects the concentration of the ligand. Determining whether any of these biochemical mechanisms regulate Xmad activity may help us understand how morphogenetic signals control cell fates during development.
Experimental Procedures
Cloning Xmad cDNAs To identify vertebrate genes related to the Drosophila gene, Mad, and the C. elegans sequences CEM-1, CEM-2, and CEM-3, two degenerate oligonucleotides were used as PCR primers. The primers are flanked by an BamHI or EcoRI linker, 5Ј and 3Ј respectively.
The sequence of the primers, 5Ј to 3Ј, are: CGGGATCCTIGA(CT) GGI(AC)GI(TC)TICA(AG)(AG)T and CGGAATTCTA(AG)TG(AG)TAIGG (AG)TT(TGA)AT(AG)CA . These primers were used to amplify a fragment from Xenopus embryonic cDNA. RNA was isolated from embryos, and the first strand of the cDNA was synthesized with MMLV reverse transcriptase and oligo(dT). The cDNA was used as a template for the PCR with the following conditions: 1 cycle of 93ЊC for Figure 7 . Xmad Proteins Are Present in the Nucleus and Cytosol 3 min, 42ЊC for 1.5 min, 72ЊC for 1 min; then 4 cycles of 93ЊC for 1 Stage-6 oocytes, injected with 30 ng of Xmad mRNA and cultured min, 42ЊC for 1.5 min, 72ЊC for 1 min; followed by 30 cycles of 93ЊC in media containing 35 S-labeled amino acids, were fractionated, and for 1 min, 55ЊC for 1.5 min, 72ЊC for 1 min; and finally 1 cycle of total, secreted, membrane-associated, nuclear, or cytosolic pro-72ЊC for 5 min. The PCR fragments obtained were subcloned into teins were analyzed by SDS-polyacrylamide gel electrophoresis.
pBluescript KS(II) (Stratagene). The PCR fragments were sequenced The total homogenate demonstrates that Xmad-injected oocytes and individual clones were used as a probe to screen a Xenopus contain a specific Xmad protein band (arrow). Fractionation demonoocyte cDNA library (Rebagliati et al., 1985) . The entire proceedure strates that the Xmads are located in the cytosol and the nucleus.
was performed as described previously (Graff et al., 1994) . The This figure shows the results obtained with Xmad2; identical results cDNAs from the library were sequenced on both strands. A Xmad2 were obtained with Xmad1.
clone was obtained that lacked the exon in brackets in Figure 1 . Sasai et al., 1995; Schmidt et al., 1995;  XbaI and transcribed in vitro as described previously (Krieg and Wilson and Hemmati-Brivanlou, 1995) . The ectopic ex-described are listed below 5Ј to 3Ј, and both primer sets were used Green, J.B.A., New, H.V., and Smith, J.C. (1992 (1995) . Disruption newly translated proteins as described previously (Smith et al., of BMP signals in embryonic Xenopus ectoderm leads to direct 1991b; Kessler and Melton, 1995) . The culture medium containing neural induction. Genes Dev. 9, 2923-2935. the secreted proteins was isolated (Smith et al., 1991b; Kessler and He, X., Saint-Jeannet, J.P., Woodgett, J.R., Varmus, H.E., and Dawid, Melton, 1995) . Oocytes were homogenized at 4ЊC in buffer 94Aϩ I.B. (1995) . Glycogen synthase kinase-3 and dorsoventral patterning (0.25 M sucrose, 20 mM HEPES [pH 7.4], 50 mM KCl, 0.5 mM MgCl 2, in Xenopus embryos. Nature 374, 617-622. 1 mM K-EGTA [pH 7.4], 1 mM PMSF, 1 g/ml leupeptin), and this Hemmati-Brivanlou, A., and Melton, D.A. (1992) . A truncated activin fraction is termed total in Figure 6 . After removing the yolk by low receptor dominantly inhibits mesoderm induction and formation of speed centrifugation at 1000 ϫ g for 5 min at 4ЊC, the membrane axial structures in Xenopus embryos. Nature 359, 609-614. and cytosolic fractions were isolated by centrifugation at 100,000 ϫ g for 45 min at 4ЊC (Evans and Kay, 1991) . The nuclei were isolated Hemmati-Brivanlou, A., and Thomsen, G.H. (1995) . Ventral mesoderby manual dissection (Evans and Kay, 1991) . One oocyte equivalent mal patterning in Xenopus embryos: expression patterns and activiof each compartment was analyzed by 10% SDS-PAGE in the presties of BMP-2 and BMP-4. Dev. Genet. 17, 78-89. ence of the reducing agent dithiothreitol.
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